Table 2.
Crude and adjusted associations (standardised β-coefficients) between change in PAEE, 
and total body movement with standardised subcomponents of the metabolic summary score and the whole score (zMS) at follow-up in the ProActive cohort over 1 year
| Outcome (SD) | Standardised β-coefficient (95% CI) | |||||
|---|---|---|---|---|---|---|
| Change in PAEE (n = 318) | Change in  (n = 318) |
Change in total body movement (n = 191) | ||||
| Crude | Adjusteda | Crude | Adjusteda | Crude | Adjusteda | |
| Waist circumference | −0.061 (−0.172, 0.051) | −0.025 (−0.065, 0.016) | −0.074 (−0.185, 0.037) | −0.017 (−0.058, 0.024) | −0.117 (−0.261, 0.027) | −0.019 (−0.071, 0.032) |
| Systolic blood pressure | 0.062 (−0.047, 0.171) | 0.074 (−0.004, 0.152) | −0.017 (−0.126, 0.093) | −0.035 (−0.113, 0.044) | −0.017 (−0.158, 0.125) | 0.012 (−0.094, 0.118) |
| Logged triacylglycerol | −0.008 (−0.127, 0.110) | −0.024 (−0.100, 0.051) | −0.059 (−0.178, 0.060) | −0.009 (−0.084, 0.067) | −0.026 (−0.180, 0.128) | −0.054 (−0.149, 0.041) |
| Logged fasting insulin | −0.064 (−0.175, 0.046) | −0.024 (−0.093, 0.045) | −0.094 (−0.203, 0.016) | −0.069 (−0.137, −0.002)b | −0.097 (−0.239, 0.045) | −0.101 (−0.186, −0.017)b |
| Fasting plasma glucose | −0.005 (−0.133, 0.123) | −0.024 (−0.114, 0.067) | −0.139 (−0.266, −0.012)b | −0.090 (−0.180, 0.000)b | −0.163 (−0.328, 0.002) | −0.147 (−0.259, −0.035)b |
| HDL-cholesterol (inverse) | −0.053 (−0.165, 0.059) | −0.056 (−0.125, 0.014) | −0.115 (−0.227, −0.004)b | −0.097 (−0.166, −0.029)b | −0.027 (−0.167, 0.113) | −0.026 (−0.121, 0.069) |
| zMS | −0.031 (−0.112, 0.050) | −0.017 (−0.054, 0.020) | −0.081 (−0.160, −0.001)b | −0.056 (−0.093, −0.020)b | −0.074 (−0.176, 0.028) | −0.066 (−0.111, −0.021)b |
| zMS-ob | −0.023 (−0.103, 0.058) | −0.012 (−0.053, 0.029) | −0.083 (−0.163, −0.004)b | −0.062 (−0.102, −0.022)b | −0.065 (−0.166, 0.037) | −0.068 (−0.119, −0.016)b |
aAll coefficients adjusted for age, sex, smoking status, SES, waist circumference and baseline phenotype, except for waist circumference, which was adjusted for age, sex, smoking status, SES and baseline phenotype
bp < 0.05